業績

Maeda T, Kitamura S, Yanagi T,  Narahira A, Miyamoto K, Hata H, Cho KY, Kameda H, Nakamura A, Shimizu H.

Type 1 diabetes mellitus in a melanoma patient treated with adjuvant nivolumab therapy.

Journal of Cutaneous Immunology and Allergy. 2019.

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Metin-Armagan D, Comunoglu N, Bulut G, Kadioglu P, Kameda H, Gazioglu N, Tanriover N, Ozturk M.
A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
Endocrine Pathology. 2019. PMID: 31828584

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nomoto H, Montemurro C, Pei L, Rosenberger M, Furterer A, Coppola G, Nadel B, Pellegrini M, Gurlo T, Butler PC, Tudzarova S.

Activation of the HIF1α/PFKFB3 stress response pathway in beta-cells in type 1 diabetes.

Diabetologia. 2019. PMID: 31720731

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nomoto H, Gurlo T, Girgis M, Dry SM, Rosenberger M, Butler PC. 

Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes.

Case Reports in Endocrinology. 2019. 

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).

Diabetes, Obesity and Metabolism. 2019. PMID: 31486230

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Cho KY, Nakamura A, Oba-Yamamoto C, Tsuchida K, Yanagiya S, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Diabetes & Metabolism Journal. 2019. PMID: 31769240

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Montemurro C*, Nomoto H*, Pei L*, Vongbunyong KE, Vadrevu S, Gurlo T, Butler AE, Subramaniam R, Ritou E, Shirihai OS, Satin LS, Butler PC, Tudzarova S. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function. Nat Commun. 2019. PMID: 31213603 (*: joint first authors)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sekizaki T, Kameda H, Oba C, Cho KY, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation. Endocr J, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T. Gitelman’s Syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report. Medicine, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes. J Diabetes Investig in press. (PMID: 31026373)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著